Clinical trial

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

NCT04214210

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-04-15

PhaseNA

Study timeline

Study start (actual)2022-04-15Date precision: day

Registry last updated2026-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hereditary Cancerunresolved

Breast Cancerunresolved

Ovarian Cancerunresolved

Interventions

Adapted Family Gene ToolkitOTHER

Targeted interventionOTHER

Sponsors & collaborators

University of Basellead sponsor

Yonsei Universitycollaborator

University Hospital, Basel, Switzerlandcollaborator

Hopital du Jura, Delemont, Switzerlandcollaborator

Department of Computer Science Yonsei University, Seoul, Koreacollaborator

National Cancer Center, Koreacollaborator

Chungnam National Universitycollaborator

Ente Ospedaliero Cantonale, Ticino, Switzerlandcollaborator

Swiss National Science Foundationcollaborator

Insel Gruppe AG, University Hospital Berncollaborator

University Hospital, Genevacollaborator

Kantonal Hospital Winterthur, Medical Oncologycollaborator

Kantonal Hospital Fribourg, Breast Centercollaborator

Hirslanden, Grangettes, Genevacollaborator

Kantonal Hospital Solothurn, Oltencollaborator

Kantonal Hospital Graubundencollaborator

Kantonal Hospital Wallis, Sioncollaborator

Zurich Breast Centercollaborator

Mapped research locations

BaselSwitzerland1 BernSwitzerland1 GenevaSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04214210 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.